| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH)
AUPH Technical Analysis
4
| As on 9th Jun 2023 AUPH STOCK Price closed @ 9.99 and we RECOMMEND Sell for LONG-TERM with Stoploss of 11.44 & Strong Sell for SHORT-TERM with Stoploss of 18.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AUPHSTOCK Price
| Open | 10.47 | Change | Price | % |
| High | 10.47 | 1 Day | -0.42 | -4.03 |
| Low | 9.97 | 1 Week | 0.50 | 5.27 |
| Close | 9.99 | 1 Month | -1.08 | -9.76 |
| Volume | 2059214 | 1 Year | -10.99 | -52.38 |
| 52 Week High 23.91 | 52 Week Low 4.11 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AUPH Daily Charts |
AUPH Intraday Charts |
Whats New @ Bazaartrend |
AUPH Free Analysis |
|
|
AUPH Important Levels Intraday
| RESISTANCE | 10.95 |
| RESISTANCE | 10.64 |
| RESISTANCE | 10.45 |
| RESISTANCE | 10.26 |
| SUPPORT | 9.72 |
| SUPPORT | 9.53 |
| SUPPORT | 9.34 |
| SUPPORT | 9.03 |
AUPH Forecast May 2024
| 4th UP Forecast | 26.7 |
| 3rd UP Forecast | 21.34 |
| 2nd UP Forecast | 18.03 |
| 1st UP Forecast | 14.72 |
| 1st DOWN Forecast | 5.26 |
| 2nd DOWN Forecast | 1.95 |
| 3rd DOWN Forecast | -1.36 |
| 4th DOWN Forecast | -6.72 |
AUPH Weekly Forecast
| 4th UP Forecast | 15.64 |
| 3rd UP Forecast | 13.83 |
| 2nd UP Forecast | 12.71 |
| 1st UP Forecast | 11.59 |
| 1st DOWN Forecast | 8.39 |
| 2nd DOWN Forecast | 7.27 |
| 3rd DOWN Forecast | 6.15 |
| 4th DOWN Forecast | 4.34 |
AUPH Forecast2024
| 4th UP Forecast | 49.26 |
| 3rd UP Forecast | 36.67 |
| 2nd UP Forecast | 28.88 |
| 1st UP Forecast | 21.1 |
| 1st DOWN Forecast | -1.12 |
| 2nd DOWN Forecast | -8.9 |
| 3rd DOWN Forecast | -16.69 |
| 4th DOWN Forecast | -29.28 |
Aurinia Pharmaceuticals Inc ( NASDAQ USA Symbol : AUPH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AUPH Business Profile
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada. Address: 4464 Markham Street, Victoria, BC, Canada, V8Z 7X8
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service